Skip to content

Abstract A067: Beyond cancer: Causes of death among head and neck cancer survivors

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · 0 citations

Abstract

Cardiovascular disease (CVD) is consistently identified as one of the leading non-cancer causes of death among head and neck cancer (HNC) survivors. However, less is known about the demographic, clinical, and geographic factors associated with cardiovascular mortality in this population. We examined the risk of CVD mortality among HNC survivors, and demographic, clinical, and geographic predictors of CVD mortality. Case-level data for survivors aged ≥18 years with HNC were obtained from the Surveillance, Epidemiology, and End Results (SEER) Research Plus database (2000–2022). The outcome variable was CVD-specific mortality, defined using the SEER cause of death (COD) site recode variable. Individuals were classified as experiencing death due to CVD if the COD site recode indicated "Disease of Heart"; individuals who were alive or died from any other cause were coded as non–CVD deaths. Deaths from causes other than CVD were treated as a competing risk. Survival time was measured in months from the date of cancer diagnosis to death or censoring. Fine and Gray competing risk model was used to examine the sociodemographic, clinical, and geographic factors associated with CVD mortality. A total of 228,157 survivors with HNC were included in the study. Overall, 5.2% of survivors died from CVD. Older age was associated with higher CVD mortality risk (SHR=1.32; 95% CI, 1.29–1.36). Males had higher CVD mortality risk (1.41; 1.36–1.46) compared to females. Compared with non-Hispanic Whites, Hispanics (0.80; 0.74–0.86) and Asian/Pacific Islanders (0.68; 0.63–0.74) had lower CVD mortality risk. Those with localized stage had higher risk of CVD mortality (1.13; 1.09–1.18) whereas those with distant stage had lower risk of CVD mortality (0.82; 0.78–0.86) as compared to those with regional stage. Individuals with cancer of the hypopharynx (0.74; 0.65–0.83), nasopharynx (0.75; 0.64–0.88), oropharynx (0.67; 0.58–0.78), salivary glands (0.75; 0.66–0.85), tongue (0.74; 0.69–0.79), and tonsil (0.75; 0.70–0.80) had lower risk of CVD mortality as compared to those with gum and other mouth cancers, while those with lip cancers had higher risk of CVD mortality (1.11; 1.03–1.19). Older age, male sex, race, stage and anatomic sites are associated with CVD mortality in HNC survivors. These findings highlight the importance of incorporating cardiovascular risk assessment and management into long-term survivorship care. Future studies should evaluate whether targeted cardiovascular prevention strategies can reduce cardiovascular mortality and improve long-term outcomes among HNC survivors. Mrudula Nair, Anders S. Erickson, Minerva So, Chaitali Dagli, Pranali G. Patel, Nosayaba Osazuwa-Peters, Jason Semprini, Eric Adjei Boakye. Beyond cancer: Causes of death among head and neck cancer survivors [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr A067.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.